Denali Therapeutics (DNLI)
(Real Time Quote from BATS)
$23.75 USD
+0.22 (0.94%)
Updated Jul 23, 2024 12:18 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.68 |
EPS Last Quarter | -0.68 |
Last EPS Surprise | -1.49% |
ABR | 1.13 |
Earnings ESP
|
14.81% |
---|---|
Current Year | -2.77 |
Next Year | -2.82 |
EPS (TTM) | -0.96 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 21.20M | 28.13M | 67.23M | 186.11M |
# of Estimates | 7 | 6 | 7 | 6 |
High Estimate | 33.38M | 36.90M | 124.00M | 367.25M |
Low Estimate | 3.00M | 20.00M | 20.00M | 105.00M |
Year ago Sales | 294.12M | 1.27M | 330.53M | 67.23M |
Year over Year Growth Est. | -92.79% | 2,114.96% | -79.66% | 176.81% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.68 | -0.67 | -2.77 | -2.82 |
# of Estimates | 12 | 10 | 13 | 11 |
Most Recent Consensus | -0.72 | -0.71 | -2.85 | -2.86 |
High Estimate | -0.53 | -0.49 | -2.37 | -1.31 |
Low Estimate | -0.80 | -0.82 | -3.14 | -3.32 |
Year ago EPS | 1.30 | -0.72 | -1.06 | -2.77 |
Year over Year Growth Est. | -152.31% | 6.94% | -161.32% | -1.79% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.68 | -0.67 | -2.77 | -2.82 |
7 Days Ago | -0.68 | -0.67 | -2.77 | -2.82 |
30 Days Ago | -0.69 | -0.69 | -2.78 | -2.86 |
60 Days Ago | -0.68 | -0.67 | -2.77 | -2.83 |
90 Days Ago | -0.68 | -0.68 | -2.61 | -2.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.58 | -0.69 | -2.70 | -2.75 |
Zacks Consensus Estimate | -0.68 | -0.67 | -2.77 | -2.82 |
Earnings ESP | 14.81% | -3.14% | 2.42% | 2.36% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.68 | -0.86 | -0.72 | 1.30 | NA |
Estimate | -0.67 | -0.82 | -0.83 | -0.86 | NA |
Difference | -0.01 | -0.04 | 0.11 | 2.16 | 0.56 |
Surprise | -1.49% | -4.88% | 13.25% | 251.16% | 64.51% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more